Biopharmaceutical company AstraZeneca India (AstraZeneca Pharma India Limited) on Wednesday announced that it has signed a memorandum of understanding with Bengaluru-based health startup, Docon Technologies, for digitising 1,000 clinics across India. Under the partnership, Docon will equip the identified clinics with customised Electronic Medical Record (EMR) systems enabling clinicians to access complete patient history, a joint statement said. "This willgo a long way in helping the clinical community better treat chronic patients and manage long-term complications of non-communicable diseases (NCDs) like diabetes and cardiovascular diseases', it said. Towards reaching the 1,000 clinics goal in 2021, on ground identification and support has been placed in 30 cities. Till now, as a part of the pilot phase, around 200 clinics have been upgraded with many of them being in Tier 1 & 2 towns, the statement said. In addition to providing the clinicians with a three day ..
SII Chief Executive Officer Adar Poonawalla said on Monday he had taken it up at the "highest levels".
The African countries have received the Covishield jab from WHO-led Covax
This study, published on the Lancet pre-print server, means all possible vaccination schedules involving the Oxford-AstraZeneca and Pfizer-BioNTech vaccines could potentially be used against Covid-19
Booster given six months after the 2nd dose beneficial, shows Oxford research
Reports suggest India plans to take this matter of non-inclusion of Covishield in the list of approved vaccines for European Union (EU) 'Green Pass' up with the EU
AstraZeneca vaccine immune response higher with longer gap, More than 50% kids in Mumbai have Covid-19 antibodies, according to a sero survey, and other top news of the day
Leaving a gap of as long as 10 months between the first and second doses increased level of protective antibodies, says Oxford University research.
British-Swedish biopharmaceutical firm AstraZeneca has in partnership with the University of Oxford rolled out human trials for booster shots against Beta Covid variant
A single dose of Pfizer or AstraZeneca Covid-19 vaccine offers around 60 per cent protection against infection
A single dose of either the Pfizer or AstraZeneca Covid-19 vaccine offers around 60 per cent protection against infection from SARS-CoV-2, the virus causing Covid-19, in adults aged 65 years and above
Between 30 to 40 countries are unable to provide second doses of a Covid-19 vaccine, especially those expecting jabs from AstraZeneca, officials of the World Health Organization (WHO) said.
The WHO is urgently trying to work with AstraZeneca, Serum Institute of India (SII) as well as the Indian government to restart shipments of Covid-19 vaccines to countries
A Brussels court has ordered AstraZeneca to deliver an additional 50 million doses of Covid-19 vaccines to EU member states by September or face a maximum of 500 mn euros ($593 mn) in fines
AstraZeneca now looks forward to renewed collaboration with the European Commission to help combat the pandemic in Europe.
Thailand was slated to receive and administer 6 million AstraZeneca vaccine doses in June but health authorities this week said they would be distributing only 3.5 million of those shots this month
Canada's National Advisory Committee on Immunization said Thursday people who got the AstraZeneca vaccine as their first dose should get Pfizer-BioNTech or Moderna for their second shot
The trial of 1,121 adult volunteers looked at whether the long-acting antibody combination could protect people who had recently been in contact with the SARS-CoV-2 virus in places like care homes.
Vaccines from Pfizer Inc. and AstraZeneca Plc protect against delta, researchers said Monday
Italy on Friday suspended the use of the AstraZeneca vaccine for people under 60 years old, health officials announced at a weekly press conference on the Covid-19 pandemic